April 8th Biotech Update

While it looked like today was going to be a flat week of consolidation, the last couple of days have been a disappointment and this is more of a pullback sort of week.  Pullbacks are not bad per se as long as it stays above support and I think if we stay above $90 and […]

April 7th Biotech Update

It has been an up and down week and while some of the moves felt trend like, i.e. that they would be part of a more sustained move to the upside or downside, it seems like the week is one of sideways.  There are still two trading days to make the week one of green […]

April 6th Biotech Update

We had a good day and then a bad day and hopefully we have another good day.  The sector is doing well (or at least better than it has been for a long time). It has been awhile since the sector looked to be setting up an uptrend and while we have been disappointed before, […]

April 1st Biotech Update

It is not an April Fools Day joke but the sector outperformed the broader markets for the March and I think was even barely green.  While I think we would want more than barely green and would want an even greater outperformance, it has to be a positive sign for the sector to outperform in […]

March 31st Biotech Update

The sector looked like it was going to have a nice continuation day yesterday but the afternoon ended up being a mess.  It is nice to see that it is not continued into this morning but we really do not want to start the pattern of green in the morning only to reverse later in […]

March 30th Biotech Update

The sector has had a good start to the week but we are not getting the big positive news that could really amp the move higher.  As I noted the idea scenario would be this positive momentum to coincide with some sector meaningful positive news but not yet.  This is not to say it is […]

March 25th Biotech Update

Still not a lot of news in the sector.  I am encouraged that we continue to maintain this range and consolidate at these levels.  The key next will be to break out of this range to the upside and ideally it is done on the back of some positive fundamental news (M&A or positive data […]

March 24th Biotech Update

The sector started weak and then had a nice recovery but then reverse back to the downside. I would not read too much into it as we basically remain in the range formed from the last move higher.  As long as we do not make a move back towards the recent lows, we could see […]

March 23 Biotech Update

The sector seems to be in a decent place.  This is not to say I am very bullish but it has been doing well and as long as it stays above $88 I think this could be a pause that refreshes.  We have had a nice move to this range from the recent lows and […]

March 25th Biotech Update

Not much news this morning.  The world is still here and while the stalemate continues in the Ukraine the lack of escalation probably keeps the market calm.  There is still tremendous violence ongoing but at this point the market seems to have priced in the stalemate.  I still think the stalemate breaks at some point […]

March 18th Biotech Update

It has been quite the week for the sector.  We have been fooled before but I hesitate to say that this feels different.  There was bad news in terms of the interest rate increase as well as signaling for more.  There has not been really good company news this week and we still have a […]

March 17th Biotech Update

The stalemate in Ukraine likely remains good for the market.  I am not convinced that the stalemate can last for months but it is more likely a week or two hiatus.  As long as it looks like escalation is not happening or at risk of happening then the market looks the other way.  Of course, […]

March 14th Biotech (and Ukraine) Update

Not much has changed in the Ukraine.  This is probably a positive for the market but this stalemate cannot last indefinitely.  If the Ukrainians are successfully hitting the Russian supply lines (as it appears) then the Russian forces will soon (another week or so) have very little supplies left that they will be unable to […]

March 11th Biotech (and Ukraine and Energy) Update

The market and conflict in the Ukraine tough to read right now.  Things have more or less settled into a stalemate in the Ukraine and the market is probably OK with that but this stalemate is not sustainable.  The Ukrainians have been degrading the Russia supplies and this degrades Russian capabilities and increases the chance […]

March 9 Biotech (and Energy) Update

Has the market adjusted to the conflict in the Ukraine?  Commodities are cooling off, VIX is going down and risk assets (and the market) are going higher.  As I noted, I think the market decline has passed if the conflict does not expand or escalate.  The situation has been simmering at the current levels for […]

February 18th Biotech (and Ukraine) Update

We have more of the same today.  The crisis in Ukraine is only escalating as we head into a long weekend and there are no indications that this escalation will decrease.  I have the feeling that as we get closer to the end of trading that investors will think less and less favorably about being […]